This paper investigates optimal consumption, investment, and healthcare spending under Epstein-Zin preferences. Given consumption and healthcare spending plans, Epstein-Zin utilities are defined over an agent's random lifetime, partially controllable by the agent as healthcare reduces Gompertz' natural growth rate of mortality. In a Black-Scholes market, the stochastic optimization problem is solved through the associated Hamilton-Jacobi-Bellman (HJB) equation. Compared with classical Epstein-Zin utility maximization, the additional controlled mortality process complicates the uniqueness of Epstein-Zin utilities and verification arguments. A combination of probabilistic arguments and analysis of the HJB equation are required to resolve the challenges. In contrast to prior work under time-separable utilities, Epstein-Zin preferences largely facilitate calibration. In five different countries we examined, the model-generated mortality closely approximates actual mortality data; moreover, the calibrated efficacy of healthcare is in close agreement with empirical studies on healthcare across countries.
This paper investigates optimal consumption, investment, and healthcare spending under Epstein-Zin preferences. Given consumption and healthcare spending plans, Epstein-Zin utilities are defined over an agent's random lifetime, partially controllable by the agent as healthcare reduces Gompertz' natural growth rate of mortality. In a Black-Scholes market, the stochastic optimization problem is solved through the associated Hamilton-Jacobi-Bellman (HJB) equation. Compared with classical Epstein-Zin utility maximization, the additional controlled mortality process complicates the uniqueness of Epstein-Zin utilities and verification arguments. A combination of probabilistic arguments and analysis of the HJB equation are required to resolve the challenges. In contrast to prior work under time-separable utilities, Epstein-Zin preferences largely facilitate calibration. In four different countries we examined, the model-generated mortality closely approximates actual mortality data; moreover, the calibrated efficacy of healthcare is in broad agreement with empirical studies on healthcare across countries.
R
five
four
R
close
broad